Anti-apoptotic gene transcription signature of salivary gland neoplasms

BMC Cancer

Volumn 12, Issue , 2012, Pages

  Gomes, Carolina C ^a   Bernardes, Vanessa F ^a   Diniz, Marina G ^a   De Marco, Luiz ^a   Gomez, Ricardo S ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Apoptosis; Bax; Bcl 2; Caspase 3; Cell proliferation; P53; Pleomorphic adenoma; Salivary gland neoplasms; Transcription; Tumour size

Indexed keywords

CASPASE 3; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53;

ACTB GENE; ANTIAPOPTOSIS GENE; APOPTOSIS; APOPTOSIS GENE; ARTICLE; BAX GENE; BCL 2 GENE; CANCER SIZE; CARCINOGENESIS; CASP3 GENE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; GENE FUNCTION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PROGNOSIS; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; SALIVARY GLAND CANCER; SALIVARY GLAND DISEASE; TRANSCRIPTION REGULATION; TRANSCRIPTION SIGNATURE; TUMOR GENE; GENE EXPRESSION PROFILING; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALIVARY GLAND TUMOR;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CELL PROLIFERATION; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; PROTO-ONCOGENE PROTEINS C-BCL-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SALIVARY GLAND NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84856571509     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-61     Document Type: Article

References (21)

1. Eveson JW, Auclair P, Gnepp DR, El-Naggar AK. Tumours of the salivary glands: introduction. Pathology & Genetics Head and Neck Tumours 2005, 212-215. Lyon: IARC Press, Barnes L, Eveson JW, Reichart P, Sidransky D, 3273695, 22324016.
2. Ettl T, Schwarz S, Kleinsasser N, Hartmann A, Reichert TE, Driemel O. Overexpression of EGFR and absence of C-KIT expression correlate with poor prognosis in salivary gland carcinomas. Histopathology 2008, 53(5):567-577. 10.1111/j.1365-2559.2008.03159.x, 18983466.
3. Chandana SR, Conley BA. Salivary gland cancers: current treatments, molecular characteristics and new therapies. Expert Rev Anticancer Ther 2008, 8(4):645-652. 10.1586/14737140.8.4.645, 18402531.
4. Cotter TG. Apoptosis and cancer: the genesis of a research field. Nat Rev Cancer 2009, 9(7):501-507. 10.1038/nrc2663, 19550425.
5. Tsujimoto Y, Finger LR, Yunis J, Nowell PC, Croce CM. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science 1984, 226(4678):1097-1099. 10.1126/science.6093263, 6093263.
6. Sasi N, Hwang M, Jaboin J, Csiki I, Lu B. Regulated cell death pathways: new twists in modulation of BCL2 family function. Mol Cancer Ther 2009, 8(6):1421-1429. 10.1158/1535-7163.MCT-08-0895, 3091595, 19509269.
7. Certo M, Del Gaizo Moore V, Nishino M, Wei G, Korsmeyer S, Armstrong SA, et al. Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members. Cancer Cell 2006, 9(5):351-365. 10.1016/j.ccr.2006.03.027, 16697956.
8. Antonsson B. Bax and other pro-apoptotic Bcl-2 family "killer-proteins" and their victim, the mitochondrion. Cell Tissue Res 2001, 306(3):347-361. 10.1007/s00441-001-0472-0, 11735035.
9. Creagh EM, Martin SJ. Caspases: cellular demolition experts. Biochem Soc Trans 2001, 29(pt6):696-702.
10. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 1995, 376(6535):37-43. 10.1038/376037a0, 7596430.
11. Soini Y, Törmänen U, Pääkkö P. Apoptosis is inversely related to bcl-2 but not to Bax expression in salivary gland tumours. Histopathology 1998, 32(1):28-34. 10.1046/j.1365-2559.1998.00334.x, 9522213.
12. Fujita S, Shibata Y, Takahashi H, Tsuda N. Apoptosis-induced and -suppressed cells in salivary gland adenoid cystic carcinoma: correlation with histological growth patterns. Oral Dis 1999, 5(2):117-122.
13. Yin HF, Okada N, Takagi M. Apoptosis and apoptotic-related factors in mucoepidermoid carcinoma of the oral minor salivary glands. Pathol Int 2000, 50(8):603-609. 10.1046/j.1440-1827.2000.01091.x, 10972857.
14. Aoki T, Tsukinoki K, Karakida K, Ota Y, Otsuru M, Kaneko A. Expression of cyclooxygenase-2, Bcl-2 and Ki-67 in pleomorphic adenoma with special reference to tumor proliferation and apoptosis. Oral Oncol 2004, 40(9):954-959. 10.1016/j.oraloncology.2004.04.014, 15380175.
15. Jia L, Esguerra RL, Tang X, Yin H, Sakamoto K, Okada N, et al. Prognostic value of apoptosis and apoptosis-associated proteins in salivary gland adenoid cystic carcinoma. Pathol Int 2004, 54(4):217-223. 10.1111/j.1440-1827.2004.01611.x, 15028021.
16. Ben-Izhak O, Laster Z, Araidy S, Nagler RM. TUNEL-an efficient prognosis predictor of salivary malignancies. Br J Cancer 2007, 96(7):1101-1106. 10.1038/sj.bjc.6603655, 2360125, 17325701.
17. Ben-Izhak O, Laster Z, Akrish S, Muska E, Gan S, Nagler RM. The salivary tip of the p53 mutagenesis iceberg: novel insights. Cancer Biomark 2009, 5(1):23-31.
18. Marques YM, de Lima Mde D, de Melo Alves Sde M, Soares FA, de Araújo VC, Pinto Ddos S, Mantesso A. Mdm2, p53, p21 and pAKT protein pathways in benign neoplasms of the salivary gland. Oral Oncol 2008, 44(9):903-908. 10.1016/j.oraloncology.2007.11.013, 18485798.
19. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993, 74(4):609-619. 10.1016/0092-8674(93)90509-O, 8358790.
20. Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995, 80(2):293-299. 10.1016/0092-8674(95)90412-3, 7834749.
21. Vojtěsek B, Bártek J, Midgley CA, Lane DP. An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53. J Immunol Methods 1992, 151(1-2):237-244. 10.1016/0022-1759(92)90122-A, 1378473.